Abstract
Twenty five HIV-1-infected patients, at various stages (CDC II, III and IV) were treated orally with HIV-1-specific transfer factor (TF) for periods varying from 60 to 1870 days. All patients were receiving antiviral treatments in association with TF. The number of lymphocytes, CD4 and CD8 subsets were followed and showed no statistically significant variations. In 11/25 patients the number of lymphocytes increased, whilst in 11/25 decreased; similarly an increase of the CD4 lymphocytes was observed in 11/25 patients and of the CD8 lymphocytes in 15/25. Clinical improvement or a stabilized clinical condition was noticed in 20/25 patients, whilst a deterioration was seen in 5/25. In 12/14 anergic patients, daily TF administration restored delayed type hypersensitivity to recall antigens within 60 days. These preliminary observations suggest that oral HIV-specific TF administration, in association with antiviral drugs, is well tolerated and seems beneficial to AIDS patients, thus warranting further investigation.
References
Jun 1, 1992·The Journal of Infectious Diseases·M ClericiG M Shearer
Jul 15, 1991·Annals of Internal Medicine·M S GottliebK S Hillman
Jul 1, 1991·The Journal of Infectious Diseases·M ClericiC O Tacket
Feb 6, 1987·JAMA : the Journal of the American Medical Association·J T CareyJ J Ellner
Jul 1, 1986·Cellular Immunology·D VizaD A Davies
Dec 8, 1988·Nature·I AugerC E Lawrence
Mar 1, 1985·Proceedings of the Society for Experimental Biology and Medicine·E RodaL Barbara
Jan 1, 1985·Pediatric Infectious Disease·S J NelsonP G Shackelford
Sep 2, 1985·Nature·D Viza
Nov 10, 1973·Lancet·C E RossR M Mackie
Feb 1, 1967·Acta Medica Scandinavica·M Soborg, G Bendixen
May 4, 1984·Science·M PopovicR C Gallo
Aug 14, 1980·The New England Journal of Medicine·R W SteeleM M Vincent
Oct 1, 1982·Proceedings of the Society for Experimental Biology and Medicine·D V AblashiG Pizza
Jan 1, 1994·Biotherapy·G PizzaD Viza
Jan 1, 1995·Nature Medicine·S Rowland-JonesT Corrah
Jul 1, 1995·The Journal of Infectious Diseases·M J DolanG M Shearer
Sep 1, 1994·Journal of Virology·P BorrowM B Oldstone
Jan 1, 1996·Biotherapy·D Viza
Jan 1, 1996·Biotherapy·A A GottliebC H Kern
Jan 1, 1996·Biotherapy·C Fernandez-OrtegaM J Araña
Jan 1, 1996·Biotherapy·G PizzaR Baricordi
Citations
May 22, 2001·AIDS Patient Care and STDs
Nov 3, 2011·BMC Research Notes·Humberto H LaraCristina Rodriguez-Padilla
Jan 1, 1996·Biotherapy·E RaiseF Gritti
Nov 16, 2004·Biochemical and Biophysical Research Communications·Celia Fernández-OrtegaLicet Rodríguez
May 16, 2014·Biotechnology and Applied Biochemistry·Jianwei ZhouZhaocai Zhang
Nov 2, 2016·Scandinavian Journal of Rheumatology·P AcostaD G Pérez
May 29, 2004·Integrative Cancer Therapies·Ralph W Moss
Jun 2, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hui ZhangJuan Li